A. Rapoport < A. Rascol < A. Remaury

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]

Ident.	Authors (with country if any)	Title
000422 (1992)	G. Durrieu [France] ; M E Llau ; O. Rascol ; J M Senard ; A. Rascol ; J L Montastruc	Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
000581 (1992)	J M Senard [France] ; B. Chamontin ; A. Rascol ; J L Montastruc	Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension.
000713 (1992)	O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J L Montastruc ; J P Marc-Vergnes ; A. Rascol	Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
000718 (1991)	J L Montastruc [France] ; O. Rascol ; J M Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol	Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
000921 (1991)	O. Rascol ; U. Sabatini ; M. Simonetta-Moreau ; J L Montastruc ; A. Rascol ; M. Clanet	Square wave jerks in parkinsonian syndromes.
000985 (1991)	U. Sabatini ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J P Marc-Vergnes ; J L Montastruc	Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.
000A21 (1991)	A. Agniel ; P. Celsis ; G. Viallard ; J L Montastruc ; O. Rascol ; J F Demonet ; J P Marc-Vergnes ; A. Rascol	Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.
000A36 (1990)	J M Senard [France] ; P. Valet ; G. Durrieu ; M. Berlan ; M A Tran ; J L Montastruc ; A. Rascol ; P. Montastruc	Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
000B36 (1991)	G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc	Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
000D54 (1990)	G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. Montastruc	Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
001023 (1990)	G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L Montastruc	Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
001119 (1990)	U. Sabatini [France] ; O. Rascol ; A. Rascol ; J L Montastruc	Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients.
001577 (1989)	M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L Montastruc	Alpha 2-adrenergic sensitivity in Parkinson's disease.
001890 (1989)	J L Montastruc ; O. Rascol ; A. Rascol	A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
001B92 (1989)	O. Rascol [France] ; M. Clanet ; J L Montastruc ; M. Simonetta ; M J Soulier-Esteve ; B. Doyon ; A. Rascol	Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems.
001C34 (1988)	O. Rascol [France] ; J L Montastruc ; J M Senard ; J F Demonet ; M. Simonetta ; A. Rascol	Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.
001C44 (1987)	M B Delisle [France] ; P. Gorce ; E. Hirsch ; J J Hauw ; A. Rascol ; H. Bouissou	Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions.
001C46 (1987)	J L Montastruc [France] ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. Rascol	Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
001C78 (1995)	O. Rascol [France] ; U. Sabatini ; N. Fabre ; J M Senard ; M. Simonetta-Moreau ; J L Montastruc ; M. Clanet ; A. Rascol	Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
001D06 (1994)	O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. Rascol	Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
001D17 (1994)	J L Montastruc ; O. Rascol ; J M Senard ; A. Rascol	A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "A. Rascol" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "A. Rascol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    A. Rascol
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024